Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 229

1.

Recurrence-Free Survival After Resection of Gastric Gastrointestinal Stromal Tumors Classified According to a Strict Definition of Tumor Rupture: A Population-Based Study.

Hølmebakk T, Hompland I, Bjerkehagen B, Stoldt S, Bruland ØS, Hall KS, Boye K.

Ann Surg Oncol. 2018 May;25(5):1133-1139. doi: 10.1245/s10434-018-6353-5. Epub 2018 Feb 12.

PMID:
29435684
2.

Therapeutic Effect of α-Emitting 224Ra-Labeled Calcium Carbonate Microparticles in Mice with Intraperitoneal Ovarian Cancer.

Westrøm S, Bønsdorff TB, Bruland ØS, Larsen RH.

Transl Oncol. 2018 Apr;11(2):259-267. doi: 10.1016/j.tranon.2017.12.011. Epub 2018 Jan 28.

3.

Ra-224 labeling of calcium carbonate microparticles for internal α-therapy: Preparation, stability, and biodistribution in mice.

Westrøm S, Malenge M, Jorstad IS, Napoli E, Bruland ØS, Bønsdorff TB, Larsen RH.

J Labelled Comp Radiopharm. 2018 Jan 29. doi: 10.1002/jlcr.3610. [Epub ahead of print]

PMID:
29380410
4.

Genotype and risk of tumour rupture in gastrointestinal stromal tumour.

Boye K, Berner JM, Hompland I, Bruland ØS, Stoldt S, Sundby Hall K, Bjerkehagen B, Hølmebakk T.

Br J Surg. 2018 Jan;105(2):e169-e175. doi: 10.1002/bjs.10743.

PMID:
29341147
5.

Palliative Treatment of Cancer-Related Pain [Internet].

Kongsgaard U, Kaasa S, Dale O, Ottesen S, Nordøy T, Hessling SE, von Hofacker S, Bruland ØS, Lyngstadaas A.

Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2005 Dec.

6.

Three-year Safety of Radium-223 Dichloride in Patients with Castration-resistant Prostate Cancer and Symptomatic Bone Metastases from Phase 3 Randomized Alpharadin in Symptomatic Prostate Cancer Trial.

Parker CC, Coleman RE, Sartor O, Vogelzang NJ, Bottomley D, Heinrich D, Helle SI, O'Sullivan JM, Fosså SD, Chodacki A, Wiechno P, Logue J, Seke M, Widmark A, Johannessen DC, Hoskin P, James ND, Solberg A, Syndikus I, Kliment J, Wedel S, Boehmer S, Dall'Oglio M, Franzén L, Bruland ØS, Petrenciuc O, Staudacher K, Li R, Nilsson S.

Eur Urol. 2017 Jul 10. pii: S0302-2838(17)30516-X. doi: 10.1016/j.eururo.2017.06.021. [Epub ahead of print]

7.

Prediction of long-term survival in patients with metastatic gastrointestinal stromal tumor: analysis of a large, single-institution cohort.

Hompland I, Bruland ØS, Hølmebakk T, Poulsen JP, Stoldt S, Hall KS, Boye K.

Acta Oncol. 2017 Oct;56(10):1317-1323. doi: 10.1080/0284186X.2017.1330555. Epub 2017 May 30.

PMID:
28557540
8.

An exploratory analysis of alkaline phosphatase, lactate dehydrogenase, and prostate-specific antigen dynamics in the phase 3 ALSYMPCA trial with radium-223.

Sartor O, Coleman RE, Nilsson S, Heinrich D, Helle SI, O'Sullivan JM, Vogelzang NJ, Bruland Ø, Kobina S, Wilhelm S, Xu L, Shan M, Kattan MW, Parker C.

Ann Oncol. 2017 May 1;28(5):1090-1097. doi: 10.1093/annonc/mdx044.

9.

Genetic landscape of sporadic vestibular schwannoma.

Håvik AL, Bruland O, Myrseth E, Miletic H, Aarhus M, Knappskog PM, Lund-Johansen M.

J Neurosurg. 2018 Mar;128(3):911-922. doi: 10.3171/2016.10.JNS161384. Epub 2017 Apr 14.

PMID:
28409725
10.

GBA2 Mutations Cause a Marinesco-Sjögren-Like Syndrome: Genetic and Biochemical Studies.

Haugarvoll K, Johansson S, Rodriguez CE, Boman H, Haukanes BI, Bruland O, Roque F, Jonassen I, Blomqvist M, Telstad W, Månsson JE, Knappskog PM, Bindoff LA.

PLoS One. 2017 Jan 4;12(1):e0169309. doi: 10.1371/journal.pone.0169309. eCollection 2017.

11.

Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome.

Fluge Ø, Mella O, Bruland O, Risa K, Dyrstad SE, Alme K, Rekeland IG, Sapkota D, Røsland GV, Fosså A, Ktoridou-Valen I, Lunde S, Sørland K, Lien K, Herder I, Thürmer H, Gotaas ME, Baranowska KA, Bohnen LM, Schäfer C, McCann A, Sommerfelt K, Helgeland L, Ueland PM, Dahl O, Tronstad KJ.

JCI Insight. 2016 Dec 22;1(21):e89376. doi: 10.1172/jci.insight.89376.

12.

Clinical implications of repeated drug monitoring of imatinib in patients with metastatic gastrointestinal stromal tumour.

Hompland I, Bruland ØS, Ubhayasekhera K, Bergquist J, Boye K.

Clin Sarcoma Res. 2016 Dec 15;6:21. doi: 10.1186/s13569-016-0062-2. eCollection 2016.

13.

Multimodal treatment of craniofacial osteosarcoma with high-grade histology. A single-center experience over 35 years.

König M, Osnes TA, Lobmaier I, Bjerkehagen B, Bruland ØS, Sundby Hall K, Meling TR.

Neurosurg Rev. 2017 Jul;40(3):449-460. doi: 10.1007/s10143-016-0802-z. Epub 2016 Nov 17.

PMID:
27858303
14.

Evaluation of CD146 as Target for Radioimmunotherapy against Osteosarcoma.

Westrøm S, Bønsdorff TB, Abbas N, Bruland ØS, Jonasdottir TJ, Mælandsmo GM, Larsen RH.

PLoS One. 2016 Oct 24;11(10):e0165382. doi: 10.1371/journal.pone.0165382. eCollection 2016.

15.

Genome Analysis of Osteosarcoma Progression Samples Identifies FGFR1 Overexpression as a Potential Treatment Target and CHM as a Candidate Tumor Suppressor Gene.

Barøy T, Chilamakuri CS, Lorenz S, Sun J, Bruland ØS, Myklebost O, Meza-Zepeda LA.

PLoS One. 2016 Sep 29;11(9):e0163859. doi: 10.1371/journal.pone.0163859. eCollection 2016.

16.

Serum BAFF and APRIL Levels, T-Lymphocyte Subsets, and Immunoglobulins after B-Cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Myalgic Encephalopathy/Chronic Fatigue Syndrome.

Lunde S, Kristoffersen EK, Sapkota D, Risa K, Dahl O, Bruland O, Mella O, Fluge Ø.

PLoS One. 2016 Aug 18;11(8):e0161226. doi: 10.1371/journal.pone.0161226. eCollection 2016.

17.

Efficacy and Safety of Radium-223 Dichloride in Symptomatic Castration-resistant Prostate Cancer Patients With or Without Baseline Opioid Use From the Phase 3 ALSYMPCA Trial.

Parker C, Finkelstein SE, Michalski JM, O'Sullivan JM, Bruland Ø, Vogelzang NJ, Coleman RE, Nilsson S, Sartor O, Li R, Seger MA, Bottomley D.

Eur Urol. 2016 Nov;70(5):875-883. doi: 10.1016/j.eururo.2016.06.002. Epub 2016 Jun 22.

18.

Definition and clinical significance of tumour rupture in gastrointestinal stromal tumours of the small intestine.

Hølmebakk T, Bjerkehagen B, Boye K, Bruland Ø, Stoldt S, Sundby Hall K.

Br J Surg. 2016 May;103(6):684-691. doi: 10.1002/bjs.10104. Epub 2016 Mar 14.

PMID:
26988241
19.

Metastatic mesenteric dedifferentiated leiomyosarcoma: a case report and a review of literature.

Varghese M, Bruland O, Wiedswang AM, Lobmaier I, Røsok B, Benjamin RS, Hall KS.

Clin Sarcoma Res. 2016 Feb 24;6:2. doi: 10.1186/s13569-016-0042-6. eCollection 2016.

20.

Adenoviral Mediated Expression of BMP2 by Bone Marrow Stromal Cells Cultured in 3D Copolymer Scaffolds Enhances Bone Formation.

Sharma S, Sapkota D, Xue Y, Sun Y, Finne-Wistrand A, Bruland O, Mustafa K.

PLoS One. 2016 Jan 25;11(1):e0147507. doi: 10.1371/journal.pone.0147507. eCollection 2016.

21.

Negative and Positive Consequences of Cancer Treatment Experienced by Long-term Osteosarcoma Survivors: A Qualitative Study.

Fauske L, Bondevik H, Bruland ØS, Ozakinci G.

Anticancer Res. 2015 Nov;35(11):6081-90.

PMID:
26504033
22.

Can Imatinib Be Safely Withdrawn in Patients with Surgically Resected Metastatic GIST?

Hompland I, Bruland ØS.

Anticancer Res. 2015 Nov;35(11):5759-65. Review.

PMID:
26503996
23.

Clinical Epidemiology of Low-Grade and Dedifferentiated Osteosarcoma in Norway during 1975 and 2009.

Berner K, Johannesen TB, Bruland ØS.

Sarcoma. 2015;2015:917679. doi: 10.1155/2015/917679. Epub 2015 Aug 30.

24.

S100A16 promotes differentiation and contributes to a less aggressive tumor phenotype in oral squamous cell carcinoma.

Sapkota D, Bruland O, Parajuli H, Osman TA, Teh MT, Johannessen AC, Costea DE.

BMC Cancer. 2015 Sep 9;15:631. doi: 10.1186/s12885-015-1622-1.

25.

B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment.

Fluge Ø, Risa K, Lunde S, Alme K, Rekeland IG, Sapkota D, Kristoffersen EK, Sørland K, Bruland O, Dahl O, Mella O.

PLoS One. 2015 Jul 1;10(7):e0129898. doi: 10.1371/journal.pone.0129898. eCollection 2015.

26.

Development of congenital stromal corneal dystrophy is dependent on export and extracellular deposition of truncated decorin.

Mellgren AE, Bruland O, Vedeler A, Saraste J, Schönheit J, Bredrup C, Knappskog PM, Rødahl E.

Invest Ophthalmol Vis Sci. 2015 May;56(5):2909-15. doi: 10.1167/iovs.14-16014.

PMID:
26029887
27.

Cured of primary bone cancer, but at what cost: a qualitative study of functional impairment and lost opportunities.

Fauske L, Bruland OS, Grov EK, Bondevik H.

Sarcoma. 2015;2015:484196. doi: 10.1155/2015/484196. Epub 2015 Apr 9.

28.

Extraskeletal osteosarcoma in Norway, between 1975 and 2009, and a brief review of the literature.

Berner K, Bjerkehagen B, Bruland ØS, Berner A.

Anticancer Res. 2015 Apr;35(4):2129-40.

PMID:
25862869
29.

Radium-223 in the treatment of osteoblastic metastases: a critical clinical review.

Humm JL, Sartor O, Parker C, Bruland OS, Macklis R.

Int J Radiat Oncol Biol Phys. 2015 Apr 1;91(5):898-906. doi: 10.1016/j.ijrobp.2014.12.061. Review.

PMID:
25832684
30.

Prognostic factors and treatment results of high-grade osteosarcoma in norway: a scope beyond the "classical" patient.

Berner K, Hall KS, Monge OR, Weedon-Fekjær H, Zaikova O, Bruland ØS.

Sarcoma. 2015;2015:516843. doi: 10.1155/2015/516843. Epub 2015 Feb 17.

31.

Influence of multiple UV exposures on serum cobalamin and vitamin D levels in healthy females.

Juzeniene A, Baturaite Z, Lagunova Z, Grigalavicius M, Porojnicu AC, Bruland ØS, Moan J.

Scand J Public Health. 2015 May;43(3):324-30. doi: 10.1177/1403494815572206. Epub 2015 Mar 4.

PMID:
25740614
32.

Primary bone cancer in Leonbergers may be associated with a higher bodyweight during adolescence.

Anfinsen KP, Grotmol T, Bruland OS, Trangerud C, Jonasdottir TJ.

Prev Vet Med. 2015 Apr 1;119(1-2):48-53. doi: 10.1016/j.prevetmed.2015.02.003. Epub 2015 Feb 14. Erratum in: Prev Vet Med. 2015 Jun 15;120(2):252. Trangerud, Cathrine [added].

PMID:
25732913
33.

Vitamin D levels and dietary intake among patients with benign soft tissue tumors and sarcomas.

Juzeniene A, Porojnicu AC, Baturaite Z, Lagunova Z, Aksnes L, Bruland ØS, Moan J.

Anticancer Res. 2015 Feb;35(2):1171-80.

PMID:
25667508
34.

STUB1 mutations in autosomal recessive ataxias - evidence for mutation-specific clinical heterogeneity.

Heimdal K, Sanchez-Guixé M, Aukrust I, Bollerslev J, Bruland O, Jablonski GE, Erichsen AK, Gude E, Koht JA, Erdal S, Fiskerstrand T, Haukanes BI, Boman H, Bjørkhaug L, Tallaksen CM, Knappskog PM, Johansson S.

Orphanet J Rare Dis. 2014 Sep 26;9:146. doi: 10.1186/s13023-014-0146-0.

35.

177Lu-DOTA-HH1, a novel anti-CD37 radio-immunoconjugate: a study of toxicity in nude mice.

Repetto-Llamazares AH, Larsen RH, Giusti AM, Riccardi E, Bruland ØS, Selbo PK, Dahle J.

PLoS One. 2014 Jul 28;9(7):e103070. doi: 10.1371/journal.pone.0103070. eCollection 2014.

36.

Advantage of lutetium-177 versus radioiodine immunoconjugate in targeted radionuclide therapy of b-cell tumors.

Repetto-Llamazares A, Abbas N, Bruland ØS, Dahle J, Larsen RH.

Anticancer Res. 2014 Jul;34(7):3263-9.

PMID:
24982330
37.

Time-trends on incidence and survival in a nationwide and unselected cohort of patients with skeletal osteosarcoma.

Berner K, Johannesen TB, Berner A, Haugland HK, Bjerkehagen B, Bøhler PJ, Bruland ØS.

Acta Oncol. 2015 Jan;54(1):25-33. doi: 10.3109/0284186X.2014.923934. Epub 2014 Jun 24.

38.

Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial.

Sartor O, Coleman R, Nilsson S, Heinrich D, Helle SI, O'Sullivan JM, Fosså SD, Chodacki A, Wiechno P, Logue J, Widmark A, Johannessen DC, Hoskin P, James ND, Solberg A, Syndikus I, Vogelzang NJ, O'Bryan-Tear CG, Shan M, Bruland ØS, Parker C.

Lancet Oncol. 2014 Jun;15(7):738-46. doi: 10.1016/S1470-2045(14)70183-4. Epub 2014 May 13.

PMID:
24836273
39.

Response to preoperative chemotherapy in patients undergoing resection of pulmonary metastasis from soft tissue sarcoma - a predictor of outcome?

Ohnstad HO, Bruland OS, Taksdal I, Bjerkehagen B, Nenadovic M, Sæter G, Jørgensen LH, Hall KS.

Acta Oncol. 2014 Sep;53(9):1180-7. doi: 10.3109/0284186X.2014.899433. Epub 2014 Apr 3.

PMID:
24697744
40.

Radiotherapy for spinal metastases from breast cancer with emphasis on local disease control and pain response using repeated MRI.

Switlyk MD, Bruland ØS, Skjeldal S, Hald JK, Seierstad T, Zaikova O.

J Bone Oncol. 2014 Mar 12;3(1):5-9. doi: 10.1016/j.jbo.2014.02.003. eCollection 2014 Mar.

41.

Malignant phyllodes tumor and acute megakaryoblastic leukemia sharing a common clonal origin.

Fløisand Y, Beiske K, Tjønnfjord GE, Heldal D, Bjerkehagen B, Revheim ME, Heim S, Bruland OS, Hall KS, Tierens A, Delabie J.

Case Rep Hematol. 2013;2013:934781. doi: 10.1155/2013/934781. Epub 2013 Dec 17.

42.

Two cases with fatal outcome following total lung irradiation for metastatic bone sarcoma.

Lia K, Bruland ØS, Randem HL, Aksnes LH, Poulsen JP, Taksdal I, Sundby Hall K.

J Bone Oncol. 2013 Oct 11;2(4):174-9. doi: 10.1016/j.jbo.2013.09.002. eCollection 2013 Dec.

43.

The clinical impact of mean vessel size and solidity in breast carcinoma patients.

Mikalsen LT, Dhakal HP, Bruland ØS, Naume B, Borgen E, Nesland JM, Olsen DR.

PLoS One. 2013 Oct 11;8(10):e75954. doi: 10.1371/journal.pone.0075954. eCollection 2013.

44.

Reply to 'comment on no association of primary Sjögren's syndrome with Fcγ receptor gene variants'.

Haldorsen K, Bruland O, Appel S, Bolstad AI.

Genes Immun. 2013 Dec;14(8):532. doi: 10.1038/gene.2013.51. Epub 2013 Oct 10. No abstract available.

PMID:
24108103
45.

S100A14 interacts with S100A16 and regulates its expression in human cancer cells.

Sapkota D, Costea DE, Ibrahim SO, Johannessen AC, Bruland O.

PLoS One. 2013 Sep 27;8(9):e76058. doi: 10.1371/journal.pone.0076058. eCollection 2013.

46.

Biologic targets identified from dynamic 18FDG-PET and implications for image-guided therapy.

Rusten E, Rødal J, Bruland Ø, Malinen E.

Acta Oncol. 2013 Oct;52(7):1378-83. doi: 10.3109/0284186X.2013.813071. Epub 2013 Aug 28.

PMID:
23981046
47.

De novo Huntington disease caused by 26-44 CAG repeat expansion on a low-risk haplotype.

Houge G, Bruland O, Bjørnevoll I, Hayden MR, Semaka A.

Neurology. 2013 Sep 17;81(12):1099-100. doi: 10.1212/WNL.0b013e3182a4a4af. Epub 2013 Aug 14. No abstract available.

48.

Alpha emitter radium-223 and survival in metastatic prostate cancer.

Parker C, Nilsson S, Heinrich D, Helle SI, O'Sullivan JM, Fosså SD, Chodacki A, Wiechno P, Logue J, Seke M, Widmark A, Johannessen DC, Hoskin P, Bottomley D, James ND, Solberg A, Syndikus I, Kliment J, Wedel S, Boehmer S, Dall'Oglio M, Franzén L, Coleman R, Vogelzang NJ, O'Bryan-Tear CG, Staudacher K, Garcia-Vargas J, Shan M, Bruland ØS, Sartor O; ALSYMPCA Investigators.

N Engl J Med. 2013 Jul 18;369(3):213-23. doi: 10.1056/NEJMoa1213755.

49.

Incidence and mortality of second sarcomas - a population-based study.

Bjerkehagen B, Småstuen MC, Hall KS, Skjeldal S, Bruland ØS, Smeland S, Johannesen TB, Fosså SD.

Eur J Cancer. 2013 Oct;49(15):3292-302. doi: 10.1016/j.ejca.2013.05.017. Epub 2013 Jun 17.

PMID:
23787025
50.

Patterns of local recurrence and dose fractionation of adjuvant radiation therapy in 462 patients with soft tissue sarcoma of extremity and trunk wall.

Jebsen NL, Engellau J, Engström K, Bauer HC, Monge OR, Muren LP, Eide GE, Trovik CS, Bruland OS.

Int J Radiat Oncol Biol Phys. 2013 Aug 1;86(5):949-55. doi: 10.1016/j.ijrobp.2013.04.015. Epub 2013 May 29.

Supplemental Content

Loading ...
Support Center